The Nasdaq Narrowly avoided posting its worst January in history, with a 3.4% gain to end the month. But is the rally for real, or is there more trouble to come. Plus, biotech has been a big laggard in recent months, but one top analyst has names he thinks are ready to play catch-up. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
Fler avsnitt av CNBC's "Fast Money"
Visa alla avsnitt av CNBC's "Fast Money"CNBC's "Fast Money" med CNBC finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
